Effect of Cis-9-cetylmyristoleate in Sub-healthy Subjects Presenting With Knee Joint Pain

Clinical Trial ID NCT02800759

PubWeight™ 0.00^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02800759

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines.	Osteoarthritis Cartilage	2008	10.99
2	American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee.	Arthritis Care Res (Hoboken)	2012	9.25
3	OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009.	Osteoarthritis Cartilage	2010	7.52
4	OARSI guidelines for the non-surgical management of knee osteoarthritis.	Osteoarthritis Cartilage	2014	5.81
5	EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).	Ann Rheum Dis	2004	4.94
6	OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence.	Osteoarthritis Cartilage	2007	4.34
7	Increasing prevalence of knee pain and symptomatic knee osteoarthritis: survey and cohort data.	Ann Intern Med	2011	3.65
8	The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review.	Osteoarthritis Cartilage	2011	3.17
9	Prevalence of self-reported pain, joint complaints and knee or hip complaints in adults aged ≥ 40 years: a cross-sectional survey in Herne, Germany.	PLoS One	2013	0.90